OMCL Stock Summary and Trading Ideas (Omnicell | NASDAQ:OMCL)

Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.

Omnicell trades on the NASDAQ stock market under the symbol OMCL.

As of January 6, 2025, OMCL stock price declined to $44.71 with 318,100 million shares trading.

OMCL has a beta of -0.76, meaning it tends to be less sensitive to market movements. OMCL has a correlation of 0.03 to the broad based SPY ETF.

OMCL has a market cap of $2.05 billion. This is considered a Mid Cap stock.

Last quarter Omnicell reported $282 million in Revenue and $.56 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.16.

In the last 3 years, OMCL traded as high as $168.49 and as low as $25.12.

The top ETF exchange traded funds that OMCL belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.

OMCL has outperformed the market in the last year with a price return of +32.0% while the SPY ETF gained +28.7%. OMCL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +5.5% and +0.5%, respectively, while the SPY returned +4.2% and +0.1%, respectively.

OMCL support price is $44.33 and resistance is $46.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OMCL shares will trade within this expected range on the day.